Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

16:52
10/07/16
10/07
16:52
10/07/16
16:52

Mylan up 7.7% after DoJ EpiPen settlement, FY16 guidance cut

  • 07

    Oct

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

09/22/16
ARGS
09/22/16
NO CHANGE
ARGS
Mylan weakness creates good entry point, says Argus
After Mylan's stock fell 17% over the last month, Argus analyst Jacob Kilstein thinks that the stock has reached an attractive entry point, He says that the company's new generic EpiPen will cannibalize branded sales but should help it beat upcoming generic competitors. He thinks that the stock is undervalued and keeps a Buy rating on the stock.
09/23/16
BERN
09/23/16
NO CHANGE
BERN
Mylan generic Epipen to lower EPS by about 10%, says Bernstein
Bernstein analyst Aaron Gal estimates that Mylan's decision to introduce a generic version of its EpiPen will create a drag of about 10% on its EPS. After viewing the Congressional hearings on the device, Gal continues to believe that a competitor to EpiPen will hit the market before the end of 2018. He keeps a $60 price target and Outperform rating on Mylan.
09/30/16
LEER
09/30/16
NO CHANGE
Target $45
LEER
Outperform
Mylan price target cut to $45 on lower EpiPen estimates at Leerink
Leerink analyst Jason Gerberry lowered his EpiPen sales forecasts by 33-45% from 2017-2021 in light of recent company updates, including its plan to launch an authorized generic of the emergency treatment later this year. While Mylan "appears on the right side of the law" regarding the latest Medicaid rebate controversy, Gerberry believes investors should consider the risk of a future settlement related to the issue. He cut his price target on Mylan shares to $45 from $55, but keeps an Outperform rating on the stock as he sees cash flows being sufficient to justify the current price.
10/04/16
JPMS
10/04/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan price target lowered to $52 from $62 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Mylan to $52 saying he remains cautious on the shares over the near-term given the ongoing Epipen controversy. The analyst, however, views the stock as "very inexpensive" and keeps an Overweight rating on the name. Schott sees a limited long-term impact to his thesis from the Epipen controversy and believes Mylan's generics business is underappreciated. He maintains an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ADTN

Adtran

$19.50

-0.2 (-1.02%)

05:30
01/17/18
01/17
05:30
01/17/18
05:30
Earnings
Adtran reports Q4 adj. EPS 5c, consensus (4c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

PSTG

Pure Storage

$16.16

-0.31 (-1.88%)

05:27
01/17/18
01/17
05:27
01/17/18
05:27
Upgrade
Pure Storage rating change  »

Pure Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

PSDO

Presidio

$17.74

-0.96 (-5.13%)

05:25
01/17/18
01/17
05:25
01/17/18
05:25
Downgrade
Presidio rating change  »

Presidio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.61

-0.28 (-0.97%)

05:24
01/17/18
01/17
05:24
01/17/18
05:24
Downgrade
Juniper rating change  »

Juniper downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

, MRVL

Marvell

$23.58

-0.26 (-1.09%)

05:22
01/17/18
01/17
05:22
01/17/18
05:22
Upgrade
Integrated Device, Marvell rating change  »

Integrated Device…

IDTI

Integrated Device

$31.75

-0.54 (-1.67%)

MRVL

Marvell

$23.58

-0.26 (-1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

WWR

Westwater Resources

$1.01

-0.0449 (-4.26%)

05:20
01/17/18
01/17
05:20
01/17/18
05:20
Hot Stocks
Westwater Resources confirms receipt of $1.5M from Laramide, provides update »

Westwater Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$163.85

0.71 (0.44%)

, AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

05:20
01/17/18
01/17
05:20
01/17/18
05:20
Upgrade
IBM, Amazon.com, Microsoft rating change  »

IBM upgraded to…

IBM

IBM

$163.85

0.71 (0.44%)

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

MSFT

Microsoft

$88.35

-1.25 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

  • 18

    Mar

HPQ

HP Inc.

$22.88

-0.04 (-0.17%)

05:15
01/17/18
01/17
05:15
01/17/18
05:15
Downgrade
HP Inc. rating change  »

HP Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

WPZ

Williams Partners

$43.01

-0.18 (-0.42%)

05:14
01/17/18
01/17
05:14
01/17/18
05:14
Downgrade
Williams Partners rating change  »

Williams Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$32.59

-0.62 (-1.87%)

05:14
01/17/18
01/17
05:14
01/17/18
05:14
Downgrade
Williams rating change  »

Williams downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGYF

Whitecap Resources

$7.69

0.0258 (0.34%)

05:13
01/17/18
01/17
05:13
01/17/18
05:13
Upgrade
Whitecap Resources rating change  »

Whitecap Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WES

Western Gas Partners

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Western Gas Partners rating change  »

Western Gas Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

WGP

Western Gas Equity

$41.76

-0.36 (-0.85%)

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Western Gas Equity rating change  »

Western Gas Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VLP

Valero Energy Partners

$46.58

-0.11 (-0.24%)

05:11
01/17/18
01/17
05:11
01/17/18
05:11
Downgrade
Valero Energy Partners rating change  »

Valero Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

TRGP

Targa Resources

$50.75

-0.69 (-1.34%)

05:10
01/17/18
01/17
05:10
01/17/18
05:10
Upgrade
Targa Resources rating change  »

Targa Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

PAGP

Plains GP Holdings

$23.41

-0.73 (-3.02%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Plains GP Holdings rating change  »

Plains GP Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

PAA

Plains All American

$22.90

-1.06 (-4.42%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Plains All American rating change  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 07

    Feb

PSXP

Phillips 66 Partners

$55.73

0.58 (1.05%)

05:09
01/17/18
01/17
05:09
01/17/18
05:09
Downgrade
Phillips 66 Partners rating change  »

Phillips 66 Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

OKE

Oneok

$58.80

0.13 (0.22%)

05:08
01/17/18
01/17
05:08
01/17/18
05:08
Upgrade
Oneok rating change  »

Oneok upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$38.28

-0.5 (-1.29%)

05:07
01/17/18
01/17
05:07
01/17/18
05:07
Downgrade
MPLX rating change  »

MPLX downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKL

Delek Logistics

$32.40

-0.1 (-0.31%)

05:07
01/17/18
01/17
05:07
01/17/18
05:07
Downgrade
Delek Logistics rating change  »

Delek Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AETUF

ARC Resources

$11.15

-0.19 (-1.68%)

05:06
01/17/18
01/17
05:06
01/17/18
05:06
Downgrade
ARC Resources rating change  »

ARC Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$27.25

0.35 (1.30%)

05:06
01/17/18
01/17
05:06
01/17/18
05:06
Upgrade
Crestwood Equity rating change  »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

BWP

Boardwalk Pipeline

$13.63

-0.09 (-0.66%)

05:05
01/17/18
01/17
05:05
01/17/18
05:05
Upgrade
Boardwalk Pipeline rating change  »

Boardwalk Pipeline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGP

Antero Midstream GP

$21.00

-0.04 (-0.19%)

05:03
01/17/18
01/17
05:03
01/17/18
05:03
Downgrade
Antero Midstream GP rating change  »

Antero Midstream GP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.